Our Services
Clinical Operations
Regulatory Affairs
Pharmacovigilance
Medical Affairs
Data Management
Biostatistics & Clinical Programming
Clinical Trial Drug Sourcing
Global Storage & Distribution
Secondary Packaging & Labelling
Global Project Management
Patient Access
Real World Evidence
Our Company
About Us
Our People
Patient Advocacy
Case Studies
Careers
Life at Bionical Emas
Vacancies
Press
Events
Contact Us
Social account link
Social account link
Social account link
Our Services
Clinical Operations
Regulatory Affairs
Pharmacovigilance
Medical Affairs
Data Management
Biostatistics & Clinical Programming
Clinical Trial Drug Sourcing
Global Storage & Distribution
Secondary Packaging & Labelling
Global Project Management
Patient Access
Real World Evidence
Our Company
About Us
Our People
Patient Advocacy
Careers
Life at Bionical Emas
Vacancies
Press
Events
Contact Us
Social account link
Social account link
Social account link
Press Release
Bionical Emas launches Managed Access Program for JZP 458 – a recombinant Crisantaspase produced in Pseudomonas fluorescens
8 April 2021
Download here
